je.st
news
Tag: breast cancer
Mother, 43, who survived breast cancer, covers her body in...
2014-12-26 17:28:30| Airlines - Topix.net
The carefree Facebook pictures of an Obama motorcade driver, 24, who admits she had no security training, had never driven a van before and is stunned that anyone would 'trust' her to drive US veterinarian finally freed from Timorese jail after four months following her arrest for sharing cab with stranger who was smuggling meth - but officials STILL won't return her passport It's your fault you're fat! No-nonsense diet guru The Grit Doctor is back... and she says juicing and fasting just DON'T work Delta Air Lines passenger live tweets emergency landing after unruly traveller makes threats on flight from Atlanta to Los Angeles 'We are taking a stand for freedom': Christmas Day screenings of The Interview sell out across the country as thousands brush off hackers' 9/11-style attack threats Sony hackers fail to deliver 'Christmas gift' they promised would ruin studio as The Interview ... (more)
Microwave Imaging System Could Improve Breast Cancer Screening
2014-12-18 17:08:33| rfglobalnet Home Page
As a possible complement to routine mammography, a new microwave imaging system may be able to detect whether a lump is benign or malignant. The system provides 3D reconstructions of tissue, which are obtained without compressing the breast.
Tags: system
improve
cancer
screening
Oncothyreon makes breast cancer drug deal with Array, stock surges Friday
2014-12-15 16:30:40| Biotech - Topix.net
Oncothyreon Inc. on Friday said it made a licensing deal with Array BioPharma Inc. regarding a breast cancer drug that received "positive preliminary data" in two recent trials, and its shares rose sharply on the news. In the licensing deal for ONT-380, Oncothyreon will pay Array $20 million upfront and up to $280 million in possible milestone payments.
At 2014 San Antonio Breast Cancer Symposium three new Myriad studies highlighted
2014-12-13 11:24:24| Biotech - Topix.net
Myriad Genetics, Inc. has announced results from a new study that demonstrated the ability of the myRisk Hereditary Cancer test to detect 105 percent more mutations in cancer causing genes than conventional BRCA testing alone. The Company also presented two key studies in triple negative breast cancer that show the myChoice HRD test accurately predicted response to platinum-based therapy in patients with early-stage TNBC and that the BRACAnalysis molecular diagnostic test significantly predicted response to platinum-based drugs in patients with metastatic TNBC.
Tags: san
studies
antonio
cancer
Merck advancing breast cancer drug to mid-stage
2014-12-10 23:43:13| Biotech - Topix.net
Drugmaker Merck & Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.
Tags: drug
cancer
breast
breast cancer
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »